22nd Annual Indy Hematology ReviewTM

Saturday, March 8th 2025 | The Westin Indianapolis

Indy Hematology Review Supporters

2024 Symposium Agenda | Saturday, February 24, 2024

6:00 AM – 10:00 AMRegistration
6:45 AM – 7:25 AMBreakfast and Product Theater
6:45 AM – 4:55 PMExhibit Hall and Coffee Bar
SESSION CHAIR: Ruemu E. Birhiray, MD
7:30 AM – 7:55 AMState of the Art: 2024: Emerging Therapies in Hematologic Malignancies, Ruemu Birhiray, MD
7:55 AM – 8:15 AMTreatment of Acute Myeloid Leukemias: Managing the AML Patient When Transplant is Not an Option, Harry P. Erba, MD, PhD
8:15 AM – 8:35 AMCurrent, Emerging and Targeted Therapies for the Treatment of Relapsed and Refractory AML, Rami Komrokji, MD
8:35 AM – 9:00 AMRemoving Bad Humor and Targeting Aberrant Signaling: Treatment Strategies of Myelodysplastic Syndromes and Acute Lymphoblastic Leukemia, Richard Stone, MD IO
9:00 AM – 9:10 AMMyeloid Leukemias PANEL DISCUSSION, Harry Erba, MD, PhD, Rami Komrokji, MD, Richard Stone, MD IO
9:10 AM – 9:30 AMControversies in the Management of Chronic Myeloid Leukemia: How I Approach Patients in 2024, Richard Larson, MD
9:30 AM – 9:45 AMCoffee Break – Exhibit Hall
9:45 AM – 10:10 AMEmerging and Current Treatment of Multiple Myeloma, Kenneth Anderson, MD
10:10 AM – 10:35 AMWaldenstrom’s Macroglobulinemia: Approaching the Newly Diagnosed and Relapsed Patient, Steven Treon, MD, MA, PhD, FACP, FRCP
10:35 AM – 10:55 AMManaging Amyloidosis: How We Diagnose and Treat, Morie Gertz, MD, MACP
10:55 AM – 11:05 AMPlasma Cell Disorders PANEL DISCUSSION, Kenneth Anderson, MD, Steven Treon, MD, MA, PhD, FACP, FRCP, Morie Gertz, MD, MACP
11:05 AM – 11:15 AMCoffee Break – Exhibit Hall
11:15 AM – 11:40 AMBEYOND PAIN: Improving the Outcomes of Sickle Cell Disease with Therapeutics and Cellular Therapy in 2024, Arun Shet, MD
11:40 AM – 12:10 PMClassical Hematology: Managing Disorders of Bleeding and Clotting, Craig Kessler, MD, MACP
12:10 PM – 12:35 PMEvaluation, Diagnosis and Prognostication and Emerging Therapies for Myeloproliferative Neoplasms, Ayalew Tefferi, MD
12:35 PM – 1:00 PMMyelofibrosis, Philadelphia Chromosome Negative Myeloproliferative Neoplasms and Systemic Mastocytosis, Raajit K. Rampal, MD, PhD
1:00 PM – 1:10 PMClassical and Malignant Hematology PANEL DISCUSSION, Richard Larson, MD, Craig Kessler, MD, MACP, Ayalew Tefferi, MD, Raajit Rampal, MD, PhD, Peter Hillmen, MB, ChB, PhD  
1:10 PM – 1:55 PMLunch and Product Theaters
1:55 PM – 2:10 PMCoffee Break – Exhibit Hall
SESSION CHAIR: Michael Wiemann, MD, FACP
2:10 PM – 2:15 PM2024 IHE Named Sponsor “Community” Recognition and Presentation of T. Howard Lee Lectureship and Trophy, Michael Wiemann, MD, Ruemu E. Birhiray, MD, Sumeet Bhatia, MD
2:15 PM – 3:00 PMT. Howard Lee Keynote Lecture: The Emerging Story of Complementopathies: Treatment of Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia, Robert A. Brodsky, MD
3:00 PM – 3:05 PMQuestions and Answers
3:05 PM- 3:30 PMImmune Effector Cell Therapy for Lymphoid Malignancies: What to Do and Know in Community Oncology Practice, Tycel Phillips, MD
3:30 PM – 3:35 PMIntroduction, Presentation and Sponsorship Acknowledgement of Steven Coutre Lecture Medal by the Board of Directors of Indy Hematology Education, Donna Birhiray, OTR, MBA, Jennifer Terry, Thalia Hammond 
3:35 PM – 4:05 PMAnnual Steven Coutre Chronic Lymphocytic Leukemia Memorial Lecture: Targeted Therapies in Hematologic Disorders Treatment Considerations for Initial Therapy of Chronic Lymphocytic Leukemia, Peter Hillmen, MB, ChB, PhD
4:05 PM – 4:35 PMChronic Lymphocytic Leukemia: Evaluating and Therapeutic Approaches for the Management of the Relapsed/Refractory Patient, Jennifer Woyach, MD
4:35 PM – 4:40 PMQuestions and Answers
4:40 PM – 4:55 PMCoffee Break – Exhibit Hall
4:55 PM – 5:20 PMWhen Not to Watch and Wait: Emerging Strategies in the Treatment of Indolent Lymphoma and Mantle Cell Lymphoma, Michael E. Williams, MD, ScM, FACP
5:20 PM – 5:45 PMCurrent Advances in the treatment of Aggressive B and T Cell Lymphomas, Sonali M. Smith, MD, FASCO
5:45 PM – 6:10 PMEmerging and Current Treatment for Hodgkin Lymphoma, Stephen M. Ansell, M.D., Ph.D.
6:10 PM – 6:35 PMImmune Effector Cell Therapy for Multiple Myeloma: What to Do and Know in Community Oncology Practice, Saad Z. Usmani, MD, MBA, FACP, FRCP
6:35 PM – 7:00 PMHematopoietic Transplantation and Cellular Therapies: When to Refer and Managing Complications, Richard Childs, MD
7:00 PM – 7:15 PMLymphoid Malignancies and Cellular Therapies PANEL DISCUSSION,  Ruemu Birhiray, MD, Chair and Moderator
 Tycel Phillips, MD, Peter Hillmen, MB, ChB, PhD, Jennifer Woyach, MD, Michael Williams, MD, Sonali Smith, MD, FASCO, Stephen Ansell, MD, PhD, Saad Usmani, MD, MBA, FACP, Richard Childs, MD
7:15 PM – 7:30 PMHors D’oeuvres
7:30 PM – 8:30 PMHematologic Malignancies Townhall
 Ruemu E Birhiray, MD – Chair and Moderator
 Michael Wiemann, MD, FACP – Co-Chair
 Richard Childs, MD, Hematopoietic Stem Cell Transplantation
 Morie Gertz, MD, MACP – Plasma Cell Disorders and Amyloidosis
 Jennifer Woyach, MD – Chronic Lymphocytic Leukemia
 Rami Komrokji, MD – Acute Leukemias and Myelodysplastic Syndromes
 Matthew Lunning DO, FACP – Lymphomas
 Tycel Phillips, MD – Lymphomas
 Saad Z. Usmani, MD, MBA, FACP, FRCP – Multiple Myeloma
 Ayalew Tefferi, MD – Myeloproliferative Neoplasms

 

Nursing and Allied Providers Symposium Agenda

Moderator: Donna M. Birhiray, OTR, MBA
Thalia Hammond

6:00 AM – 10:00 AMRegistration
6:45 AM – 7:25 AMBreakfast and Product Theater
6:45 AM – 4:55 PMExhibit Hall and Coffee Bar
7:30 AM – 7:55 AMState of the Art: 2024: Emerging Therapies in Hematologic Malignancies, Ruemu Birhiray, MD
8:10 AM – 8:35 AMEmerging and Current Treatment of Waldenstrom’s Macroglobulinemia, Steven Treon, MD, MA, PhD, FACP, FRCP
8:35 AM – 9:00 AMCurrent Approaches in the Treatment of Myeloproliferative Neoplasms, Ayalew Tefferi, MD
9:00 AM – 9:30 AMManaging Disorders of the Benign Hematology, Craig Kessler, MD, MACP
9:30 AM – 9:45 AMCoffee Break – Exhibit Hall
9:45 AM –10:15 AMUnderstanding the Diagnosis and Treatment of Plasma Cell Disorders and Amyloidosis, Saad Z. Usmani, MD, MBA, FACP, FRCP
10:15 AM – 10:45 AMUnderstanding and Managing Immune Effector Toxicities in Hematologic Toxicities, David Reeves, PharmD, BCOP
10:45 AM – 11:15 AMManagement of Long-Term Survivors of Hematologic Malignancies, Sandra Garofalo, MS, APRN, AOCNP
11:15 AM – 11:30 AMCoffee Break – Exhibit Hall
11:30 AM – 11:55 AMRecognizing Toxicities of Oral Oncolytics in the Management of Hematologic Malignancies, Kristi K Orbaugh RN, MSN, RNP, AOCN
11:55 AM – 12:25 PMCurrent and Emerging Therapies for Acute Myeloid Leukemias and Myelodysplastic Syndromes, Rami Komrokji, MD
12:25 PM – 12:55 PMHow I treat Chronic Myeloid Leukemia: Understanding and Addressing, Richard Larson, MD
12:55 PM – 1:00 PMQuestion and Answers
1:10 PM – 1:55 PMLunch and Product Theaters
1:55 PM – 2:10 PMCoffee Break – Exhibit Hall
2:10 PM – 8:30 PMAll join the Main Symposium
Presentation Downloads